Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
Rasha Itani, Mansour Tobaiqy, Achraf Al Faraj
Theranostics (2020) Vol. 10, Iss. 13, pp. 5932-5942
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang, Jian Shang, Shibo Jiang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 416
Nanotechnology-based disinfectants and sensors for SARS-CoV-2
Sepehr Talebian, Gordon G. Wallace, Avi Schroeder, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 618-621
Open Access | Times Cited: 309
Triboelectric Nanogenerators for Therapeutic Electrical Stimulation
Giorgio Conta, Alberto Libanori, Trinny Tat, et al.
Advanced Materials (2021) Vol. 33, Iss. 26
Closed Access | Times Cited: 162
Nanotechnology Responses to COVID‐19
Eduardo Ruiz‐Hitzky, Margarita Darder, Bernd Wicklein, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 19
Open Access | Times Cited: 155
COVID-19: Progress in diagnostics, therapy and vaccination
Xue Liu, Chao Liu, Gang Liu, et al.
Theranostics (2020) Vol. 10, Iss. 17, pp. 7821-7835
Open Access | Times Cited: 148
Potentialities of bioinspired metal and metal oxide nanoparticles in biomedical sciences
Kshitij RB Singh, Vanya Nayak, Jay Singh, et al.
RSC Advances (2021) Vol. 11, Iss. 40, pp. 24722-24746
Open Access | Times Cited: 128
Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects
Afreen Sultana, Mina Zare, Vinoy Thomas, et al.
Medicine in Drug Discovery (2022) Vol. 15, pp. 100134-100134
Open Access | Times Cited: 110
Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review
Mohit Kumar, Ayah Rebhi Hilles, Samah Hamed Almurisi, et al.
JCIS Open (2023) Vol. 12, pp. 100095-100095
Open Access | Times Cited: 43
Nanoparticles as delivery vehicles for antiviral therapeutic drugs
Alexander Maus, Lia Strait, Donghui Zhu
Engineered Regeneration (2021) Vol. 2, pp. 31-46
Open Access | Times Cited: 94
Zinc-Based Nanomaterials for Diagnosis and Management of Plant Diseases: Ecological Safety and Future Prospects
Anu Kalia, Kamel A. Abd–Elsalam, Kamil Kuča
Journal of Fungi (2020) Vol. 6, Iss. 4, pp. 222-222
Open Access | Times Cited: 89
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 215-239
Open Access | Times Cited: 89
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
Valamla Bhavana, Pradip Thakor, Shashi Bala Singh, et al.
Life Sciences (2020) Vol. 261, pp. 118336-118336
Open Access | Times Cited: 81
Chitin and chitosan as tools to combat COVID-19: A triple approach
Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 235-244
Open Access | Times Cited: 68
Antiviral Properties of Silver Nanoparticles against SARS-CoV-2: Effects of Surface Coating and Particle Size
Qinghao He, Jing Lü, Nian Liu, et al.
Nanomaterials (2022) Vol. 12, Iss. 6, pp. 990-990
Open Access | Times Cited: 45
A clinical perspective of chitosan nanoparticles for infectious disease management
Fahima Dilnawaz, Sarbari Acharya, Anwesha Kanungo
Polymer Bulletin (2023) Vol. 81, Iss. 2, pp. 1071-1095
Open Access | Times Cited: 23
Chitosan biopolymer and its composites: Processing, properties and applications- A comprehensive review
Abinash Das, Sampad Ghosh, Nabakumar Pramanik
Hybrid Advances (2024) Vol. 6, pp. 100265-100265
Open Access | Times Cited: 8
Exploring the role of triazole functionalized heteroatom co-doped carbon quantum dots against human coronaviruses
Piyush Garg, Sujata Sangam, Dakshi Kochhar, et al.
Nano Today (2020) Vol. 35, pp. 101001-101001
Open Access | Times Cited: 63
Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges
Ling Ding, Siyuan Tang, Todd A. Wyatt, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 977-991
Closed Access | Times Cited: 57
Nanomedicine strategies to target coronavirus
Marcel Alexander Heinrich, B Martina, Jai Prakash
Nano Today (2020) Vol. 35, pp. 100961-100961
Open Access | Times Cited: 55
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 171-171
Open Access | Times Cited: 53
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
Iago Dillion Lima Cavalcanti, Mariane Cajubá de Britto Lira Nogueira
Journal of Nanoparticle Research (2020) Vol. 22, Iss. 9
Open Access | Times Cited: 52
Nanotechnologies for intranasal drug delivery: an update of literature
Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone, et al.
Pharmaceutical Development and Technology (2021) Vol. 26, Iss. 8, pp. 824-845
Closed Access | Times Cited: 49
Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment
Yousef Rasmi, Kouass Saloua, Mahdieh Nemati, et al.
Nanomaterials (2021) Vol. 11, Iss. 7, pp. 1788-1788
Open Access | Times Cited: 45
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
Muhammad Imran Sajid, Muhammad Moazzam, Yeseom Cho, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2105-2121
Open Access | Times Cited: 40
Nanotherapeutics in COVID-19 and associated pulmonary infections
Zahanat Muneer Mir, Parul Thakur, Rimpi Arora, et al.
Elsevier eBooks (2025), pp. 371-400
Closed Access
Page 1 - Next Page

Scroll to top